SCHEMBL26036899

SCHEMBL26036899

CCOCCn1c(C(=O)O)cc2cc(C)cc(C)c21

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
GPR35 Q9HC97 3/20 0.38
MCL1 Q07820 2/20 0.37
HCAR3 P49019 1/20 0.36
ALDH1A1 P00352 3/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CCR2 P41597 2/20 0.33
POLB P06746 2/20 0.33
NTRK1 P04629 1/20 0.33
CYP1A2 P05177 1/20 0.33
FDPS P14324 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CCR9 P51686 1/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26581649 0.87 MCL1 (0.38) KDM4EGPR35MCL1ALDH1A1HPGD
SCHEMBL26581456 0.86 ALDH1A1 (0.40) KDM4EGPR35MCL1ALDH1A1HPGD
SCHEMBL23809535 0.85 KDM4E (0.36) KDM4EGPR35MCL1HCAR3ALDH1A1
SCHEMBL26036872 0.83 MCL1 (0.37) KDM4EGPR35MCL1ALDH1A1HPGD
SCHEMBL6703975 0.75 ALDH1A1 (0.42) KDM4EGPR35ALDH1A1HPGDHSD17B10
SCHEMBL26581694 0.75 ALDH1A1 (0.44) KDM4EMCL1ALDH1A1HPGDHSD17B10
SCHEMBL26581713 0.74 CCR2 (0.37) KDM4EGPR35MCL1ALDH1A1HPGD
SCHEMBL26590807 0.73 ALDH1A1 (0.38) KDM4EGPR35MCL1ALDH1A1HPGD
SCHEMBL26581225 0.73 HSD17B10 (0.51) KDM4EGPR35MCL1ALDH1A1HPGD
SCHEMBL23809272 0.73 MCL1 (0.35) KDM4EGPR35MCL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed
EP-3423435-B1 SUBSTITUTED INDOLE MCL-1 INHIBITORS UNIV VANDERBILT (US) 2023-08-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 KDM4E 1156/4885GPR35 3148/4885MCL1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.